mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.009 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
0.009 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.009 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.009 |
mRNA |
GW 441756 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.009 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.009 |
mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
0.087 |
0.009 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.099 |
0.01 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.01 |